Novo Nordisk A/S (NVO) — Hedge Fund Ownership Q1 2026
NVO
- Novo Nordisk A/S (NVO) is held by 5 of 82 tracked hedge funds, with Maverick Capital (1%) and Markel Group (1%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
- The biggest increases in NVO holdings came from Causeway Capital Management (+18%), highlighting conviction.
- Overall, hedge funds increased exposure to Novo Nordisk A/S (NVO) by +5% vs the prior quarter and +33% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Maverick Capital Lee Ainslie
|
0.89% | 2.1M | NEW | — | $76.4M | $36.75 | — |
| 2 |
Markel Group Tom Gayner
|
0.88% | 2.9M | — | +33.48% | $105.5M | $36.75 | — |
| 3 |
Causeway Capital Management
|
0.53% | 1.2M | +18.15% | — | $43.2M | $36.75 | — |
| 4 |
Dodge & Cox
|
0.39% | 19.3M | NEW | — | $710.5M | $36.75 | — |
| 5 |
Giverny Capital Francois Rochon
|
0.02% | 12K | — | — | $455,700 | $36.75 | — |
| 5 | Total | — | 25.5M | +4.65% | +33.29% | $936.0M | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.